Semaglutide Cost Without Insurance in 2026

As of October 8, 2026, brand-name semaglutide without insurance costs $349 a month for the Ozempic 0.25–1 mg pen (Ozempic savings page) or the Wegovy 0.25–2.4 mg pen (Wegovy self-pay prices), and $149 to $299 for the Wegovy pill. New patients may pay $199 for their first two pen fills. List prices are $1,027.51 (Ozempic) and $1,349.02 (Wegovy).

How much does Ozempic cost without insurance?

Quick answer: $349 a month for the 0.25, 0.5 or 1 mg pen and $499 for 2 mg on Novo Nordisk’s self-pay offer, as of October 8, 2026.

As checked October 8, 2026, Novo Nordisk advertises $199 for each of the first two monthly fills of the 0.25 or 0.5 mg starting doses for eligible new patients, with fills through December 31, 2026. Ongoing prices are $349 for 0.25, 0.5 or 1 mg and $499 for 2 mg. The manufacturer defines a month as one box containing one pen. Eligibility and changeable terms apply; this is not a price promise for every prescription. Source: Ozempic manufacturer savings terms

How much does Wegovy cost without insurance?

Quick answer: $349 a month for Wegovy pens from 0.25 to 2.4 mg, $399 for the 7.2 mg HD pen and $149–$299 for the pill, as of October 8, 2026.

As checked October 8, 2026, manufacturer offers distinguish tablets from pens. For the 0.25 through 2.4 mg pens, the advertised ongoing price is $349 per box of four pens after any applicable introductory offer; the 7.2 mg HD pen has a separate price. Tablets have dose-specific prices and terms. Confirm the maintenance cost, not only the first fill. Source: Wegovy manufacturer savings terms

Brand semaglutide, no insurance	Price	Conditions	Source
Ozempic pen 0.25, 0.5 or 1 mg	$349	Per pen (one month), self-pay	Ozempic savings page
Ozempic pen 2 mg	$499	Per pen (one month), self-pay	Ozempic savings page
Wegovy pen 0.25–2.4 mg	$349	Per box of 4 pens (28 days), self-pay	Wegovy self-pay prices
Wegovy HD pen 7.2 mg	$399	Per box of 4 pens (28 days), self-pay	Wegovy self-pay prices
Wegovy pen 0.25 / 0.5 mg, first two fills	$199	New patients only; through December 31, 2026	Wegovy self-pay prices
Wegovy pill 1.5 / 4 / 9–25 mg	$149 / $199 / $299	Per bottle of 30 tablets, self-pay	Wegovy self-pay prices
List price: Ozempic / Wegovy	$1,027.51 / $1,349.02	Per pen (Ozempic) or package (Wegovy), before discounts; not what most people pay	NovoCare: Ozempic, NovoCare: Wegovy

All brand figures checked October 8, 2026. Novo Nordisk has announced a $675 monthly list price for Ozempic and Wegovy from January 1, 2027, and says it does not change self-pay prices (Novo Nordisk news release).

Does insurance or Medicare lower the cost of semaglutide?

Quick answer: Often. With commercial coverage, Novo’s savings offers can bring a fill to as little as $25; Medicare’s temporary GLP-1 Bridge has a $50 copay for eligible members.

Coverage depends on the drug, diagnosis, plan formulary and prior authorization. Ask about the cost after your deductible and any required clinical documentation. Commercial savings and self-pay offers have different rules. Medicare GLP-1 Bridge is a temporary program for certain eligible beneficiaries beginning in July 2026; it does not mean automatic coverage for everyone. CMS: Medicare GLP-1 Bridge eligibility

What does REMEVi’s compounded semaglutide cost?

Quick answer: From $159 per 4 weeks on the 24-week plan, or $199 every 4 weeks month-to-month. Prepaid plans are charged in full upfront.

REMEVi prices use four-week billing periods, which are not calendar months. The 12- and 24-week terms require the full total upfront. Lab work that the clinician requires for treatment is included.

Compounded preparation	Every 4 weeks	12 weeks: total upfront	24 weeks: total upfront
Injectable semaglutide	$199	$507 ($169/4 weeks)	$954 ($159/4 weeks)
Injectable tirzepatide	$269	$699 ($233/4 weeks)	$1,350 ($225/4 weeks)
Compounded oral semaglutide	$249	$687 ($229/4 weeks)	$1,290 ($215/4 weeks)

See current semaglutide and tirzepatide plan details. Compounded oral semaglutide is not an approved Wegovy, Ozempic or Rybelsus tablet. Eligibility and prescribing depend on clinical evaluation. Service is available in 49 states and Washington, DC, excluding Louisiana.

Is compounded semaglutide FDA-approved?

Quick answer: No. Compounded preparations are not FDA-approved, are not generics of Ozempic, Wegovy or any brand, and have no established clinical equivalence to them.

Compounded preparations are not FDA-approved, are not generics of the brands and do not have established clinical equivalence to them. FDA recommends their use only when an available approved product cannot meet the medical need. A lower price does not establish equal safety or effectiveness. Source: FDA: unapproved GLP-1 medicines

What should I check before choosing?

Quick answer: The product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy — and who handles side effects.

Confirm the product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy. Ask who handles side effects and what happens if clinical review does not recommend treatment. Review care options.